157 related articles for article (PubMed ID: 28830219)
1. Optimization of radiotherapy fractionation schedules based on radiobiological functions.
Pizarro F; Hernández A
Br J Radiol; 2017 Nov; 90(1079):20170400. PubMed ID: 28830219
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
3. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different fractionation schedules toward a single fraction in high-dose-rate brachytherapy as monotherapy for low-risk prostate cancer using 3-dimensional radiobiological models.
Mavroidis P; Milickovic N; Cruz WF; Tselis N; Karabis A; Stathakis S; Papanikolaou N; Zamboglou N; Baltas D
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):216-23. PubMed ID: 24331667
[TBL] [Abstract][Full Text] [Related]
5. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionation: what does it mean for prostate cancer treatment?
Liao Y; Joiner M; Huang Y; Burmeister J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):260-8. PubMed ID: 19879698
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer.
Huang BT; Lin Z; Lin PX; Lu JY; Chen CZ
Oncotarget; 2016 Jun; 7(26):40746-40755. PubMed ID: 27203739
[TBL] [Abstract][Full Text] [Related]
8. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
Song W; Battista J; Van Dyk J
Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
[TBL] [Abstract][Full Text] [Related]
9. [Construction of radiobiological models as TCP (tumor control probability) and NTCP (normal tissue complication probability): from dose to clinical effects prediction].
Chaikh A; Thariat J; Thureau S; Tessonnier T; Kammerer E; Fontbonne C; Dubray B; Balosso J; Fontbonne JM
Cancer Radiother; 2020 Jun; 24(3):247-257. PubMed ID: 32220563
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
[TBL] [Abstract][Full Text] [Related]
12. A novel dose-volume metric for optimizing therapeutic ratio through fractionation: retrospective analysis of lung cancer treatments.
Keller H; Hope A; Meier G; Davison M
Med Phys; 2013 Aug; 40(8):084101. PubMed ID: 23927363
[TBL] [Abstract][Full Text] [Related]
13. On the gEUD biological optimization objective for organs at risk in Photon Optimizer of Eclipse treatment planning system.
Fogliata A; Thompson S; Stravato A; Tomatis S; Scorsetti M; Cozzi L
J Appl Clin Med Phys; 2018 Jan; 19(1):106-114. PubMed ID: 29152846
[TBL] [Abstract][Full Text] [Related]
14. Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer.
Sukhikh ES; Sukhikh LG; Taletsky AV; Vertinsky AV; Izhevsky PV; Sheino IN
Phys Med; 2019 Jun; 62():41-46. PubMed ID: 31153397
[TBL] [Abstract][Full Text] [Related]
15. IMRT: improvement in treatment planning efficiency using NTCP calculation independent of the dose-volume-histogram.
Grigorov GN; Chow JC; Grigorov L; Jiang R; Barnett RB
Med Phys; 2006 May; 33(5):1250-8. PubMed ID: 16752559
[TBL] [Abstract][Full Text] [Related]
16. "SABER": A new software tool for radiotherapy treatment plan evaluation.
Zhao B; Joiner MC; Orton CG; Burmeister J
Med Phys; 2010 Nov; 37(11):5586-92. PubMed ID: 21158270
[TBL] [Abstract][Full Text] [Related]
17. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387
[TBL] [Abstract][Full Text] [Related]
18. Response-probability volume histograms and iso-probability of response charts in treatment plan evaluation.
Mavroidis P; Ferreira BC; Lopes Mdo C
Med Phys; 2011 May; 38(5):2382-97. PubMed ID: 21776773
[TBL] [Abstract][Full Text] [Related]
19. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
[TBL] [Abstract][Full Text] [Related]
20. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]